ABBOTT LABORATORIES Other Non-Current Liabilities
ABBOTT LABORATORIES (ABT) had Other Non-Current Liabilities of $2.54 billion as of 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-02-20
- 2025-12-31: Other Liabilities, Noncurrent $2.54B.
- 2024-12-31: Other Liabilities, Noncurrent $2.59B; Other Liabilities, Noncurrent as first filed $3.44B.
- 2023-12-31: Other Liabilities, Noncurrent $3.47B.
- 2022-12-31: Other Liabilities, Noncurrent $3.80B.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2025-12-31 | $2.54B 10-K · filed 2026-02-20 | |
| 2024-12-31 | $2.59B 10-K · filed 2026-02-20 | $3.44B 10-K · filed 2025-02-21 |
| 2023-12-31 | $3.47B 10-K · filed 2025-02-21 | |
| 2022-12-31 | $3.80B 10-K · filed 2024-02-16 | |
| 2021-12-31 | $3.69B 10-K · filed 2023-02-17 | |
| 2017-12-31 | $9.03B 10-K · filed 2018-02-16 | |
| 2016-12-31 | $4.55B 10-K · filed 2018-02-16 | |
| 2016-09-30 | $4.25B 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $4.35B 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $4.42B 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $4.86B 10-K · filed 2017-02-17 | |
| 2015-09-30 | $5.80B 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $5.95B 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $5.97B 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $5.60B 10-K · filed 2016-02-19 | $5.59B 10-K · filed 2015-02-27 |
| 2014-09-30 | $4.88B 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $4.51B 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $4.60B 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $4.78B 10-K · filed 2015-02-27 | |
| 2013-09-30 | $5.60B 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $6.14B 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $6.13B 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $9.06B 10-K · filed 2014-02-21 | $9.06B 10-K · filed 2013-02-15 |
| 2012-09-30 | $7.81B 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $8.16B 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $8.22B 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $8.23B 10-K · filed 2013-02-15 | |
| 2011-09-30 | $6.43B 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $7.07B 10-Q · filed 2011-08-04 | |
| 2011-03-31 | $7.18B 10-Q · filed 2011-05-06 | |
| 2010-12-31 | $8.02B 10-K · filed 2013-02-15 | $7.20B 10-K · filed 2011-02-18 |
| 2010-09-30 | $7.40B 10-Q · filed 2010-11-05 | |
| 2010-06-30 | $6.08B 10-Q · filed 2010-08-05 | |
| 2010-03-31 | $6.28B 10-Q · filed 2010-05-04 | |
| 2009-12-31 | $5.08B 10-K · filed 2012-02-21 | $5.20B 10-K · filed 2010-02-19 |
| 2009-09-30 | $4.37B 10-Q · filed 2009-11-06 | |
| 2009-06-30 | $4.30B 10-Q · filed 2009-08-07 | |
| 2008-12-31 | $4.60B 10-K · filed 2011-02-18 | |
| 2007-12-31 | $3.30B 10-K · filed 2010-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |